Hutchison China MediTech Limited EPS Ratio 2011-2026 | HCM

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Hutchison China MediTech Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
0.53	0.04	0.12	-0.43	-0.25	-0.18	-0.16	-0.11	-0.04	0.2	-0.64	-0.62	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
0.53	-0.64	-0.128

Quarterly EPS Ratio Hutchison China MediTech Limited

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.03	-	-	-	-0.02	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-0.02	-0.03	-0.025

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Biotechnology industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
MorphoSys AG MOR	-15.4	-	2.43 %	$ 254 M	Germany
Allakos ALLK	-2.14	-	-	$ 28.6 M	USA
Advaxis ADXS	-7.99	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	-2.52	-	0.23 %	$ 488 M	USA
AlloVir ALVR	-2.85	-	4.14 %	$ 49.1 M	USA
Compugen Ltd. CGEN	0.38	$ 2.59	-5.31 %	$ 242 M	Israel
I-Mab IMAB	-7.66	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	-24.9	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	-10.7	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	-31	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	-0.19	$ 0.88	0.34 %	$ 6.47 M	China
Biophytis SA BPTS	-0.26	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	1.51	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	1.37	$ 22.44	-1.01 %	$ 3.72 B	USA
Evogene Ltd. EVGN	-0.83	$ 0.79	-0.65 %	$ 27.9 M	Israel
Applied Molecular Transport AMTI	-3.25	-	-	$ 10.1 M	USA
Fennec Pharmaceuticals FENC	-0.34	$ 6.23	-7.01 %	$ 178 M	USA
AIkido Pharma AIKI	-1.57	-	1.93 %	$ 17.4 M	USA
Applied Therapeutics APLT	-1.42	-	-	$ 8.42 M	USA
Galapagos NV GLPG	-1.58	$ 27.99	-1.51 %	$ 2.69 B	Belgium
Aptinyx APTX	-0.96	-	-39.0 %	$ 4.57 M	USA
Avenue Therapeutics ATXI	-0.93	-	-52.27 %	$ 4.45 M	USA
ImmuCell Corporation ICCC	-0.12	$ 8.43	0.96 %	$ 76.1 M	USA
Aeterna Zentaris AEZS	-0.07	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	-2.46	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	-1.91	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	-2.1	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	-1.62	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	-2.52	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	42.2	$ 100.41	-1.62 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	-1.11	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	0.85	-	-4.8 %	$ 255 M	USA
Innoviva INVA	4.02	$ 23.19	-2.11 %	$ 1.56 B	USA
Innate Pharma S.A. IPHA	-0.66	$ 1.45	3.57 %	$ 235 M	France
Inventiva S.A. IVA	-1.27	$ 4.95	-1.3 %	$ 138 M	France
Jaguar Health JAGX	-23	$ 0.23	-5.44 %	$ 536 K	USA
Aquestive Therapeutics AQST	-0.78	$ 4.07	-0.61 %	$ 435 M	USA
Arcutis Biotherapeutics ARQT	-0.13	$ 22.53	-3.28 %	$ 2.87 B	USA
KalVista Pharmaceuticals KALV	-2.03	$ 26.7	38.77 %	$ 1.44 B	Britain
Autolus Therapeutics plc AUTL	-1.08	$ 1.43	-3.72 %	$ 381 M	Britain
Kamada Ltd. KMDA	-0.05	$ 8.16	0.12 %	$ 260 M	Israel
Aptose Biosciences APTO	-10.4	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	0.08	-	-	$ 96.9 B	Britain
AVROBIO AVRO	0.27	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	-5.97	$ 2.95	1.2 %	$ 4.86 M	Israel
BeiGene, Ltd. BGNE	0.2	-	0.49 %	$ 251 B	Cayman-islands